As of 2024-07-27, the Relative Valuation of BioLife Solutions Inc (BLFS) is (23.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.04 USD, the upside of BioLife Solutions Inc based on Relative Valuation is -197.5%.
The range of the Relative Valuation is (23.09) - (23.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 17.0x | 16.0x |
| Forward P/E multiples | 16.9x - 19.7x | 18.3x |
| Fair Price | (23.09) - (23.22) | (23.43) |
| Upside | -196.0% - -196.6% | -197.5% |
| Date | P/E |
| 2024-07-26 | -17.60 |
| 2024-07-25 | -16.86 |
| 2024-07-24 | -16.36 |
| 2024-07-23 | -16.66 |
| 2024-07-22 | -15.87 |
| 2024-07-19 | -15.39 |
| 2024-07-18 | -15.70 |
| 2024-07-17 | -16.48 |
| 2024-07-16 | -16.67 |
| 2024-07-15 | -15.23 |
| 2024-07-12 | -15.17 |
| 2024-07-11 | -15.35 |
| 2024-07-10 | -14.14 |
| 2024-07-09 | -14.05 |
| 2024-07-08 | -14.97 |
| 2024-07-05 | -14.64 |
| 2024-07-03 | -14.66 |
| 2024-07-02 | -14.81 |
| 2024-07-01 | -15.22 |
| 2024-06-28 | -15.69 |
| 2024-06-27 | -15.01 |
| 2024-06-26 | -15.73 |
| 2024-06-25 | -15.64 |
| 2024-06-24 | -15.75 |
| 2024-06-21 | -15.37 |
| 2024-06-20 | -15.25 |
| 2024-06-18 | -14.61 |
| 2024-06-17 | -14.82 |
| 2024-06-14 | -14.79 |
| 2024-06-13 | -15.04 |
| 2024-06-12 | -15.94 |
| 2024-06-11 | -15.67 |
| 2024-06-10 | -15.75 |
| 2024-06-07 | -14.86 |
| 2024-06-06 | -15.20 |
| 2024-06-05 | -15.77 |
| 2024-06-04 | -15.31 |
| 2024-06-03 | -15.56 |
| 2024-05-31 | -15.72 |
| 2024-05-30 | -15.92 |
| 2024-05-29 | -15.80 |
| 2024-05-28 | -16.20 |
| 2024-05-24 | -15.90 |
| 2024-05-23 | -15.44 |
| 2024-05-22 | -16.02 |
| 2024-05-21 | -15.87 |
| 2024-05-20 | -15.98 |
| 2024-05-17 | -16.08 |
| 2024-05-16 | -16.08 |
| 2024-05-15 | -16.83 |